[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367323-105":59,"doc-detail-367323-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pharmacokinetics-modulation-in-solid-tumors-through-thrombin-embedded-nanomedicine","Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine","","The development of anti-tumor nanomedicines faces the challenge of sustained retention and massive intratumoral distribution of chemotherapeutics. A dual prodrug nanomedicine is proposed with redox-responsive SN38 and pH-responsive thrombin, coordinating drug release with tumor acidity and reductive stress. Tumor selectivity is governed by integrin overexpression, while thrombin triggers intratumoral vascular occlusion, normalizing elevated interstitial fluid pressure to enhance accumulation and persistence of SN38. Mass spectrum mapping validates SN38 activation and broad solid-tumor distribution compared with thrombin-free controls. The strategy integrates targeted targeting, vascular occlusion, and controlled chemotherapeutic release.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pharmacokinetics-modulation-in-solid-tumors-through-thrombin-embedded-nanomedicine/367323/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pharmacokinetics-modulation-in-solid-tumors-through-thrombin-embedded-nanomedicine/367323.png","ImageObject",300,407,{"name":92,"@type":93},"Margaret","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic challenge addressed in the study?","Question",{"text":112,"@type":113},"The study targets sustained retention and massive intratumoral distribution of chemotherapeutics, which are difficult to achieve in heterogeneous tumor microenvironments.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does the dual prodrug nanomedicine achieve spatiotemporal responsiveness?",{"text":117,"@type":113},"It combines redox-responsive SN38 and pH-responsive thrombin so drug release aligns with tumor acidity and reductive stress.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does the thrombin component matter for intratumoral drug distribution?",{"text":121,"@type":113},"Thrombin induces vascular occlusion within tumors, which helps normalize elevated interstitial fluid pressure and promotes accumulation and sustained retention of the chemotherapeutic payload.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367323,1791087605,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Lin etal. Journal of Nanobiotechnology (2025) 23:268  \n[https://doi.org/10.1186/s12951-025-03302-4](https://doi.org/10.1186/s12951-025-03302-4)  \nJournal of Nanobiotechnology  \nRESEARCH Open Access  \nPharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine  \nSheng Lin 1†, Liuwei Zhang2†, Hongyan Cui2, Yue Wang3,4,5, Yang Zheng5,6, Jianhua Hu 1, Mingzhu Li5,7, Wentao Wang3,4,5, Shijia Zhang8,9, Kehui Zhou8,9, Qixian Chen2,5,10*, Xiabin Lan8,9* and Yan Zhao3,4,5*  \nAbstract  \nThe development of anti-tumor nanomedicines grapples with the critical challenge of achieving sustained retention and massive intratumoral distributions of chemotherapeutics. Herein, we attempted multifaceted prodrug nanomedicine with precise spatiotemporal responsiveness, integrating dual prodrugs—redox-responsive SN38 and pH-responsive thrombin and ensuring drug release coinciding with the striking tumor acidity and reductive stress, while its spatial selectivity is directed by the overexpression of integrins on cancerous cells. Most importantly, the thrombin component induces vascular occlusion within tumors, leading to normalization of the elevated interstitial fluid pressure and promoting accumulation of chemotherapeutic agents. This approach not only facilitates the massive intratumoral distribution of the nanomedicine but also ensures sustained retention of SN38 within the tumor microenvironment, thereby augmenting the cytotoxic potencies. Of note, the advanced mass spectrum mapping technology unprecedentedly validated the successful activation of the SN38 prodrug and massive distribution throughout the solid tumors for thrombin-containing nanomedicine, in stark to apparent entrapment in tumor vasculature and stroma for the conventional thrombin-free nanomedicine. Hence, the multifunctionalities of our proposed dual prodrug nanomedicine is underscored by its ability to actively target cancerous cells, induce vasculature occlusion, and orchestrate a controlled release of chemotherapeutic agents.  \nKeywords Solid tumor, Nanomedicine, Targeted drug delivery, Prodrug nanomedicine, Tumor microenvironmentresponsive, Synergistic anticancer therapy  \n†Sheng Lin and Liuwei Zhang contributed equally to this work.  \n*Correspondence: Qixian Chen [plasmid@zju.edu.cn](plasmid@zju.edu.cn)[ ](plasmid@zju.edu.cn)Xiabin Lan [lanxb@zjcc.org.cn](lanxb@zjcc.org.cn)[ ](lanxb@zjcc.org.cn)Yan Zhao  \n[zhaoyan@cancerhosp-ln-cmu.com](zhaoyan@cancerhosp-ln-cmu.com)  \nFull list of author information is available at the end of the article  \nIntroduction  \nThe advent of anti-tumor nanomedicines marks a significant frontier in oncological therapeutics, heralding the potential to augment drug delivery, amplify therapeutic efficacy, and attenuate systemic toxicity [1–2]. Central to this endeavor is the imperative challenge of achieving sustained retention and extensive intratumoral distribution of chemotherapeutic agents within the intricate and heterogeneous tumor microenvironment (TME)[3, 4]. The non-uniform distribution of nanomedicines within neoplastic lesions has emerged as a pivotal barrier, impeding their clinical translation and therapeutic success [5–7].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intend","cbCaiptjulF6RBAX","https://ap.wps.com/l/cbCaiptjulF6RBAX","pdf",6677603,15,"English","# Abstract\n# Introduction","[{\"question\":\"What is the main therapeutic challenge addressed in the study?\",\"answer\":\"The study targets sustained retention and massive intratumoral distribution of chemotherapeutics, which are difficult to achieve in heterogeneous tumor microenvironments.\"},{\"question\":\"How does the dual prodrug nanomedicine achieve spatiotemporal responsiveness?\",\"answer\":\"It combines redox-responsive SN38 and pH-responsive thrombin so drug release aligns with tumor acidity and reductive stress.\"},{\"question\":\"Why does the thrombin component matter for intratumoral drug distribution?\",\"answer\":\"Thrombin induces vascular occlusion within tumors, which helps normalize elevated interstitial fluid pressure and promotes accumulation and sustained retention of the chemotherapeutic payload.\"}]","Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine | PDF",1790170258,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bdf86834c985770a970732fc00008fa.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67399f2c0721fa5d185e43eff7427247.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fc5986d6a958048d0fc52670cced90c8.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fbf87281e66204a283127e9a985102e6.webp",980,1306]